Venture Med Group
VMG: Innovating cost-effective medical devices for treating peripheral artery diseases.
Founded
2000VMG: Innovating cost-effective medical devices for treating peripheral artery diseases.
Founded with the mission to innovate cost-effective medical devices, Venture Med Group (VMG) focuses on designing and developing solutions for treating peripheral artery diseases. Their flagship product, the FLEX VESSEL PREP™ SYSTEM, aims to enhance the effectiveness of interventional procedures by addressing limitations associated with traditional balloon angioplasty. VMG targets healthcare providers specializing in vascular interventions, offering a breakthrough approach to improving patient outcomes in both peripheral artery disease and arteriovenous access for dialysis.
Notable figures affiliated with VMG include Dr. Michael Lichtenberg, who has contributed valuable insights through case studies on the FLEX system. The company has garnered attention from investors interested in medical technology innovations. Key achievements include the successful development and deployment of their FLEX VESSEL PREP™ SYSTEM, which has demonstrated significant improvements in patient care and procedural efficiency. VMG's impact is marked by its commitment to advancing vascular health through innovative medical devices, positioning itself as a leader in the field of peripheral artery disease treatment.
Companies similar to Venture Med Group include Efemoral Medical, Micro Medical Solutions, Voyager Biomedical and Artventive Medical Group.
Venture Med Group was founded in 2000.
Venture Med Group's headquarters is located in Plymouth, MN, US.
As of Jan 31, 2023, Venture Med Group has disclosed funding of $28M (USD). Undisclosed round amounts are excluded.
Venture Med Group has 5 employees as of Feb 4, 2024.
